Your browser doesn't support javascript.
loading
Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients".
Pereira-Veiga, Thais; Bravo, Susana; Gómez-Tato, Antonio; Yáñez-Gómez, Celso; Abuín, Carmen; Varela, Vanesa; Cueva, Juan; Palacios, Patricia; Dávila-Ibáñez, Ana B; Piñeiro, Roberto; Vilar, Ana; Chantada-Vázquez, María Del Pilar; López-López, Rafael; Costa, Clotilde.
Afiliación
  • Pereira-Veiga T; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Bravo S; Proteomic Unit, Instituto de Investigaciones Sanitarias-IDIS, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
  • Gómez-Tato A; CITMAga, University of Santiago de Compostela (Campus Vida), Santiago de Compostela, Spain.
  • Yáñez-Gómez C; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Abuín C; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Varela V; Department of Oncology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Cueva J; Department of Oncology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Palacios P; Department of Oncology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Dávila-Ibáñez AB; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; CIBERONC, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain.
  • Piñeiro R; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; CIBERONC, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain.
  • Vilar A; Department of Gynecology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Chantada-Vázquez MDP; Proteomic Unit, Instituto de Investigaciones Sanitarias-IDIS, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
  • López-López R; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Department of Oncology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain; CIBERONC, Centro de Investig
  • Costa C; Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; CIBERONC, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain. Electronic address: clotildecnogueira@gmail.com.
Mol Cell Proteomics ; 23(5): 100774, 2024 May.
Article en En | MEDLINE | ID: mdl-38735273
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Mol Cell Proteomics Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Mol Cell Proteomics Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: España